Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Journey Medical Shares Outstanding 2020-2024 | DERM

Journey Medical shares outstanding from 2020 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
Journey Medical Annual Shares Outstanding
(Millions of Shares)
2023 18
2022 18
2021 10
2020 11
2019 10
Journey Medical Quarterly Shares Outstanding
(Millions of Shares)
2024-03-31 20
2023-12-31 18
2023-09-30 21
2023-06-30 18
2023-03-31 18
2022-12-31 18
2022-09-30 18
2022-06-30 17
2022-03-31 17
2021-12-31 10
2021-09-30 9
2021-06-30 9
2021-03-31 11
2020-12-31
2020-09-30 11
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.076B $0.079B
Journey Medical Corporation is a commercial-stage pharmaceutical company. It focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Journey Medical Corporation is based in Scottsdale, Arizona.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.315B 31.44
Chugai Pharmaceutical (CHGCY) Japan $49.021B 21.91
Takeda Pharmaceutical (TAK) Japan $41.238B 8.35
Merck (MKGAF) Germany $23.705B 22.98
Astellas Pharma (ALPMY) Japan $17.536B 27.69
Sandoz Group AG (SDZNY) Switzerland $15.102B 0.00
Neurocrine Biosciences (NBIX) United States $13.753B 37.65
Shionogi (SGIOY) Japan $13.095B 11.38
United Therapeutics (UTHR) United States $11.996B 12.79
Catalent (CTLT) United States $9.702B 0.00
Summit Therapeutics (SMMT) United States $7.666B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.404B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.648B 7.31
Revolution Medicines (RVMD) United States $6.298B 0.00
Orion OYJ (ORINY) Finland $5.637B 23.77
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Ionis Pharmaceuticals (IONS) United States $5.335B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.806B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.578B 0.00
Corcept Therapeutics (CORT) United States $3.249B 29.44
Arrowhead Pharmaceuticals (ARWR) United States $2.829B 0.00
PTC Therapeutics (PTCT) United States $2.747B 0.00
Dyne Therapeutics (DYN) United States $2.726B 0.00
Indivior (INDV) United States $2.491B 11.81
Recursion Pharmaceuticals (RXRX) United States $2.108B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.093B 11.90
Catalyst Pharmaceuticals (CPRX) United States $1.903B 18.52
Fusion Pharmaceuticals (FUSN) Canada $1.826B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.666B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.604B 24.11
Evotec AG (EVO) Germany $1.602B 0.00
Ardelyx (ARDX) United States $1.578B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.515B 0.00
Xencor (XNCR) United States $1.473B 0.00
Soleno Therapeutics (SLNO) United States $1.424B 0.00
Pacira BioSciences (PCRX) United States $1.418B 13.48
BioCryst Pharmaceuticals (BCRX) United States $1.356B 0.00
4D Molecular Therapeutics (FDMT) United States $1.274B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.146B 0.00
Cassava Sciences (SAVA) United States $1.077B 0.00
Collegium Pharmaceutical (COLL) United States $1.061B 6.35
Enliven Therapeutics (ELVN) United States $1.060B 0.00
ProKidney (PROK) United States $0.963B 0.00
Cronos Group (CRON) Canada $0.955B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.949B 14.78
Ocular Therapeutix (OCUL) United States $0.898B 0.00
USANA Health Sciences (USNA) United States $0.890B 14.56
ARS Pharmaceuticals (SPRY) United States $0.863B 0.00
Relay Therapeutics (RLAY) United States $0.836B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.816B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.768B 0.00
Sage Therapeutics (SAGE) United States $0.692B 0.00
Lyell Immunopharma (LYEL) United States $0.678B 0.00
Silence Therapeutics (SLN) United Kingdom $0.653B 0.00
Harrow (HROW) United States $0.631B 0.00
Exscientia (EXAI) United Kingdom $0.597B 0.00
Savara (SVRA) United States $0.568B 0.00
Bioventus (BVS) United States $0.537B 20.55
Siga Technologies (SIGA) United States $0.529B 6.76
Lexeo Therapeutics (LXEO) United States $0.529B 0.00
OmniAb (OABI) United States $0.527B 0.00
Heron Therapeutics (HRTX) United States $0.520B 0.00
Altimmune (ALT) United States $0.498B 0.00
KalVista Pharmaceuticals (KALV) United States $0.475B 0.00
Korro Bio (KRRO) United States $0.466B 0.00
Larimar Therapeutics (LRMR) United States $0.453B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.444B 0.00
Esperion Therapeutics (ESPR) United States $0.434B 0.00
Verve Therapeutics (VERV) United States $0.432B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.413B 0.00
Organogenesis (ORGO) United States $0.362B 68.25
Verrica Pharmaceuticals (VRCA) United States $0.353B 0.00
Tourmaline Bio (TRML) United States $0.347B 0.00
Nanobiotix S.A (NBTX) France $0.330B 0.00
Xeris Biopharma Holdings (XERS) United States $0.329B 0.00
Fractyl Health (GUTS) United States $0.322B 0.00
ESSA Pharma (EPIX) Canada $0.295B 0.00
Nature's Sunshine Products (NATR) United States $0.284B 18.05
Black Diamond Therapeutics (BDTX) United States $0.268B 0.00
Aquestive Therapeutics (AQST) United States $0.265B 0.00
Century Therapeutics (IPSC) United States $0.255B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.254B 0.00
Foghorn Therapeutics (FHTX) United States $0.247B 0.00
Avita Medical (RCEL) United States $0.240B 0.00
Metagenomi (MGX) United States $0.239B 0.00
Acrivon Therapeutics (ACRV) United States $0.234B 0.00
Nektar Therapeutics (NKTR) United States $0.232B 0.00
Akebia Therapeutics (AKBA) United States $0.226B 0.00
CytoDyn (CYDY) United States $0.223B 0.00
Eliem Therapeutics (ELYM) United States $0.223B 0.00
Aldeyra Therapeutics (ALDX) United States $0.222B 0.00
Conduit Pharmaceuticals (CDT) United States $0.221B 0.00
Pyxis Oncology (PYXS) United States $0.219B 0.00
Prelude Therapeutics (PRLD) United States $0.213B 0.00
Zevra Therapeutics (ZVRA) United States $0.195B 0.00
Elite Pharmaceuticals (ELTP) United States $0.192B 18.00
Incannex Healthcare (IXHL) Australia $0.190B 0.00
Adherex Technologies (FENC) United States $0.187B 228.33
Profound Medical (PROF) Canada $0.183B 0.00
Achieve Life Sciences (ACHV) Canada $0.182B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Telomir Pharmaceuticals (TELO) United States $0.176B 0.00
Cardiol Therapeutics (CRDL) Canada $0.176B 0.00
Galectin Therapeutics (GALT) United States $0.169B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.164B 0.00
Context Therapeutics (CNTX) United States $0.150B 0.00
MediWound (MDWD) Israel $0.149B 0.00
Regulus Therapeutics (RGLS) United States $0.148B 0.00
VAXART, INC (VXRT) United States $0.144B 0.00
OptiNose (OPTN) United States $0.121B 0.00
Citius Pharmaceuticals (CTXR) United States $0.118B 0.00
FibroGen (FGEN) United States $0.114B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.114B 7.64
Karyopharm Therapeutics (KPTI) United States $0.112B 0.00
ProPhase Labs (PRPH) United States $0.094B 0.00
PMV Pharmaceuticals (PMVP) United States $0.092B 0.00
Relmada Therapeutics (RLMD) United States $0.092B 0.00
Vivani Medical (VANI) United States $0.090B 0.00
Assertio Holdings (ASRT) United States $0.089B 4.06
SCYNEXIS (SCYX) United States $0.089B 1.25
AlloVir (ALVR) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.080B 0.00
Aclaris Therapeutics (ACRS) United States $0.075B 0.00
Tempest Therapeutics (TPST) United States $0.073B 0.00
BioLineRx (BLRX) Israel $0.066B 0.00
Champions Oncology (CSBR) United States $0.061B 0.00
Protara Therapeutics (TARA) United States $0.060B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.057B 0.00
Mural Oncology (MURA) Ireland $0.057B 0.00
Nutriband (NTRB) United States $0.055B 0.00
Carisma Therapeutics (CARM) United States $0.054B 0.00
Inotiv (NOTV) United States $0.051B 0.00
CASI Pharmaceuticals (CASI) China $0.046B 0.00
Gain Therapeutics (GANX) United States $0.045B 0.00
DURECT (DRRX) United States $0.042B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Rafael Holdings (RFL) United States $0.038B 0.00
Lipocine (LPCN) United States $0.037B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.036B 0.00
Surrozen (SRZN) United States $0.035B 0.00
Unicycive Therapeutics (UNCY) United States $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
JanOne (JAN) United States $0.028B 0.00
Viracta Therapeutics (VIRX) United States $0.027B 0.00
Oncternal Therapeutics (ONCT) United States $0.027B 0.00
BioVie (BIVI) United States $0.027B 0.00
Aptorum Group (APM) United Kingdom $0.026B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.021B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
Lyra Therapeutics (LYRA) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.019B 0.74
GlycoMimetics (GLYC) United States $0.018B 0.00
Talphera (TLPH) United States $0.017B 0.00
Nuvilex (PMCB) United States $0.017B 0.00
Alaunos Therapeutics (TCRT) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
CERo Therapeutics Holdings (CERO) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Plus Therapeutics (PSTV) United States $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
SHINECO (SISI) China $0.012B 0.00
TransCode Therapeutics (RNAZ) United States $0.011B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Universe Pharmaceuticals INC (UPC) China $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.009B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.04
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 33.17